Another glycolysis‐regulating enzyme, enolase 1, is dysregulated by multiple checkpoint pathways, and reduced glycolytic metabolism of CD8+ TIL from B16 melanomas was associated with a loss of enolase 1 enzymatic activity when compared to acute T effector cells.244. The gene discussed is ENO1; the disease is melanoma.